Shashank K R on The Use of Lumbrokinase from Eudrilus eugeniae
Shashank K R, Assistant Lecturer at Yuvaraja’s College, shared on LinkedIn:
”Cardiovascular diseases driven by thrombosis remain a major global health challenge.
Our study focuses on the isolation, purification, and biochemical characterization of lumbrikinase from Eudrilus eugeniae, demonstrating strong fibrinolytic activity, favorable kinetics, and stability under physiological conditions—highlighting its potential as a safer and effective thrombolytic agent for cardiovascular therapeutics.”
Read the full article here.
Article: Exploring the Fibrinolytic and Biochemical characteristics of Lumbrokinase enzyme from Eudrilus eugeniae for Therapeutic Use
Authors: Shashank K R, Malliah Mahadevaswamy
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 21, 2026, 15:17Leveraging Data to Drive Sustainable Care for Haemophilia and Haemoglobinopathies – NNHF
-
Aug 21, 2026, 15:04Sex Differences in Platelet Function in Type 2 Diabetes – Seminars in Thrombosis and Hemostasis
-
Aug 21, 2026, 15:04Parth Parmar: RBC Morphology – A Practical Guide to Blood Smear Interpretation
-
Aug 21, 2026, 14:32Kenneth Nollet: Building the Future of Transfusion Laboratory Science
-
Aug 21, 2026, 14:14Tareq Abadl: A Positive Antibody Screen is Not The Diagnosis
-
Aug 21, 2026, 14:08Katrina Snow։ Transfusion Trends and Quality Improvement in Sickle Cell Disease
-
Aug 21, 2026, 14:00Rucha Patil: The Power of Point-of-Care Testing in Hemostasis
-
Aug 21, 2026, 13:56Sarah Kowalski։ Supporting the Next Generation of Transfusion Laboratory Scientists
-
Aug 21, 2026, 13:51Join EHC 2026 Annual Conference